ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
EMAS position statement: TRT in older men
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 271707" data-attributes="member: 13851"><p><strong>Fig. 1. <u>Comorbidities associated with Late-onset hypogonadism</u>. Green circles refer to complications in which testosterone therapy demonstrated beneficial effects. The orange circle refers to areas of uncertainty. T: testosterone. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</strong></p><p><strong>[ATTACH=full]40111[/ATTACH]</strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong><em>2.7.1. Cardiovascular risk and testosterone treatment</em></strong></p><p></p><p></p><p><em><strong>Summary recommendation</strong></em></p><p><em><strong></strong></em></p><p><em><strong>The quality of evidence regarding the cardiovascular safety of TRT in LOH has been low. However, the most recent data have shown that testosterone treatment in older men with hypogonadism and at increased cardiovascular risk is safe, at least in terms of major adverse cardiac events.</strong> Nevertheless, a thorough evaluation of the patient's CV risk prior to TRT is mandatory, as is strict compliance with prescription guidelines regarding dose and treatment monitoring. CV risk must be re-evaluated during TRT, and <strong>patients should be informed about the lack of definitive studies on TRT's long-term effects (>3 years).</strong> TRT must not be offered as a cardio prevention therapy to frail older men until better outcome data are available.</em></p><p></p><p></p><p><strong>*low quality of evidence</strong></p><p>[ATTACH=full]40112[/ATTACH]</p></blockquote><p></p>
[QUOTE="madman, post: 271707, member: 13851"] [B]Fig. 1. [U]Comorbidities associated with Late-onset hypogonadism[/U]. Green circles refer to complications in which testosterone therapy demonstrated beneficial effects. The orange circle refers to areas of uncertainty. T: testosterone. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) [ATTACH type="full" alt="Screenshot (31503).png"]40111[/ATTACH] [I]2.7.1. Cardiovascular risk and testosterone treatment[/I][/B] [I][B]Summary recommendation The quality of evidence regarding the cardiovascular safety of TRT in LOH has been low. However, the most recent data have shown that testosterone treatment in older men with hypogonadism and at increased cardiovascular risk is safe, at least in terms of major adverse cardiac events.[/B] Nevertheless, a thorough evaluation of the patient's CV risk prior to TRT is mandatory, as is strict compliance with prescription guidelines regarding dose and treatment monitoring. CV risk must be re-evaluated during TRT, and [B]patients should be informed about the lack of definitive studies on TRT's long-term effects (>3 years).[/B] TRT must not be offered as a cardio prevention therapy to frail older men until better outcome data are available.[/I] [B]*low quality of evidence[/B] [ATTACH type="full" alt="1703037047532.png"]40112[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
EMAS position statement: TRT in older men
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top